These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 14563701)

  • 1. Involvement of cholesterol-rich lipid rafts in interleukin-6-induced neuroendocrine differentiation of LNCaP prostate cancer cells.
    Kim J; Adam RM; Solomon KR; Freeman MR
    Endocrinology; 2004 Feb; 145(2):613-9. PubMed ID: 14563701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine signaling: STATS in plasma membrane rafts.
    Sehgal PB; Guo GG; Shah M; Kumar V; Patel K
    J Biol Chem; 2002 Apr; 277(14):12067-74. PubMed ID: 11815625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polarity and lipid raft association of the components of the ciliary neurotrophic factor receptor complex in Madin-Darby canine kidney cells.
    Buk DM; Waibel M; Braig C; Martens AS; Heinrich PC; Graeve L
    J Cell Sci; 2004 Apr; 117(Pt 10):2063-75. PubMed ID: 15054106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression.
    Lee SO; Chun JY; Nadiminty N; Lou W; Gao AC
    Prostate; 2007 May; 67(7):764-73. PubMed ID: 17373716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6 inhibits the growth of prostate cancer xenografts in mice by the process of neuroendocrine differentiation.
    Wang Q; Horiatis D; Pinski J
    Int J Cancer; 2004 Sep; 111(4):508-13. PubMed ID: 15239127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of STAT3 with caveolin-1 and heat shock protein 90 in plasma membrane raft and cytosolic complexes. Preservation of cytokine signaling during fever.
    Shah M; Patel K; Fried VA; Sehgal PB
    J Biol Chem; 2002 Nov; 277(47):45662-9. PubMed ID: 12235142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6- and cyclic AMP-mediated signaling potentiates neuroendocrine differentiation of LNCaP prostate tumor cells.
    Deeble PD; Murphy DJ; Parsons SJ; Cox ME
    Mol Cell Biol; 2001 Dec; 21(24):8471-82. PubMed ID: 11713282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-6 induces neuroendocrine differentiation (NED) through suppression of RE-1 silencing transcription factor (REST).
    Zhu Y; Liu C; Cui Y; Nadiminty N; Lou W; Gao AC
    Prostate; 2014 Aug; 74(11):1086-94. PubMed ID: 24819501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the Erk mitogen-activated protein kinase pathway stimulates neuroendocrine differentiation in LNCaP cells independently of cell cycle withdrawal and STAT3 phosphorylation.
    Kim J; Adam RM; Freeman MR
    Cancer Res; 2002 Mar; 62(5):1549-54. PubMed ID: 11888934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C/EBPdelta is a downstream mediator of IL-6 induced growth inhibition of prostate cancer cells.
    Sanford DC; DeWille JW
    Prostate; 2005 May; 63(2):143-54. PubMed ID: 15486993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different associations of CD45 isoforms with STAT3, PKC and ERK regulate IL-6-induced proliferation in myeloma.
    Zheng X; Li AS; Zheng H; Zhao D; Guan D; Zou H
    PLoS One; 2015; 10(3):e0119780. PubMed ID: 25781885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multipathways for transdifferentiation of human prostate cancer cells into neuroendocrine-like phenotype.
    Zelivianski S; Verni M; Moore C; Kondrikov D; Taylor R; Lin MF
    Biochim Biophys Acta; 2001 May; 1539(1-2):28-43. PubMed ID: 11389966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAT3 mediates IL-6-induced neuroendocrine differentiation in prostate cancer cells .
    Spiotto MT; Chung TD
    Prostate; 2000 Feb; 42(3):186-95. PubMed ID: 10639189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-6 induces neuroendocrine dedifferentiation and cell proliferation in non-small cell lung cancer cells.
    Chang KT; Tsai CM; Chiou YC; Chiu CH; Jeng KS; Huang CY
    Am J Physiol Lung Cell Mol Physiol; 2005 Sep; 289(3):L446-53. PubMed ID: 15894558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-6 protects LNCaP cells from apoptosis induced by androgen deprivation through the Stat3 pathway.
    Lee SO; Lou W; Johnson CS; Trump DL; Gao AC
    Prostate; 2004 Aug; 60(3):178-86. PubMed ID: 15176047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preformed STAT3 transducer complexes in human HepG2 cells and rat hepatocytes.
    Dráber P; Dráberová L; Heneberg P; Smíd F; Farghali H; Dráber P
    Cell Signal; 2007 Nov; 19(11):2400-12. PubMed ID: 17716862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of lipid rafts with different properties from RBL-2H3 (rat basophilic leukaemia) cells.
    Radeva G; Sharom FJ
    Biochem J; 2004 May; 380(Pt 1):219-30. PubMed ID: 14769131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-6 induces prostate cancer cell growth accompanied by activation of stat3 signaling pathway .
    Lou W; Ni Z; Dyer K; Tweardy DJ; Gao AC
    Prostate; 2000 Feb; 42(3):239-42. PubMed ID: 10639195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective binding of perfringolysin O derivative to cholesterol-rich membrane microdomains (rafts).
    Waheed AA; Shimada Y; Heijnen HF; Nakamura M; Inomata M; Hayashi M; Iwashita S; Slot JW; Ohno-Iwashita Y
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):4926-31. PubMed ID: 11309501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
    Zerbini LF; Wang Y; Cho JY; Libermann TA
    Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.